In this line of thought, increased prostate cancer incidence and mortality in Black versus White men were speculatively attributed to higher levels of circulating sex steroids, to differences in AR structure and function, or to both differences in hormone levels and ancestry-associated AR variants (48–51). This evidence concerns the gene AR and prostate carcinoma.